The global Respiratory Care Devices Market is valued at $23.93 billion in 2024 and is projected to reach a value of $54.38 ...

Just 24 hours before, the man with chronic obstructive pulmonary disease (COPD) okayed the life-saving treatment ... comorbidities that weren’t in the chart. “But those side effects could ...

OUTCOME OF MECHANICAL VENTILATION IN ACUTE EXACERBATIONS OF COPD Lynn et al 11 ... the proportion electing to receive treatment declined as the likelihood of an adverse outcome increased. These data ...

history of chronic obstructive pulmonary disease (COPD), bronchiectasis, bronchitis, cystic fibrosis or pneumonia, interstitial lung disease (ILD), pulmonary tuberculosis, lung cancer and cough caused ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual condition management.

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This in-depth analysis shows that the Global Asthma and COPD Drugs Market, valued at ...

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people ...

"This may inform prescribing of glucose-lowering medications among patients with T2D and active COPD," making SGLT2 and GLP-1 drugs preferable over DPP-4 inhibitors for these patients, the group ...

The prevalence of fatigue among patients with chronic obstructive pulmonary disease (COPD) worldwide is approximately 59%, according to systematic review and meta-analysis findings published in ...

as an add-on treatment for chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype. According to InvestingPro analysis, GSK maintains strong financial health with consistent ...

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results ...